Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters

Prenatal Diagnosis

Volumn 31, Issue 6, 2011, Pages 583-588

  Zhang, Jing ^a   Lambert Messerlian, Geralyn ^a   Palomaki, Glenn E ^a   Canick, Jacob A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cigarettes; Maternal serum screening; Trisomy 18; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; DOWN SYNDROME; FEMALE; FETUS RISK; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; MATERNAL SMOKING; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TRISOMY 18;

ADULT; BIOLOGICAL MARKERS; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; SMOKING; TRISOMY; YOUNG ADULT;

EID: 79956286121     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2755     Document Type: Article

References (29)

1. Ardawi MSM, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM. 2007. The effect of cigarette or sheesha smoking on first-trimester markers of Down syndrome. Br J Obstet Gynaecol 114: 1397-1401.
2. Bartels I, Hoppe-Sievert B, Bockel B, Herold S, Caesar J. 1993. Adjustment formulas for maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol to maternal weight and smoking. Prenat Diagn 13: 123-130.
3. Bestwick JP, Huttly WJ, Wald NJ. 2008. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotropin, pregnancy-associated plasma protein A and nuchal translucency. J Med Screen 15: 204-206.
4. Crossley JA, Aitken DA, Waugh SML, Kelly T, Connor JM. 2002. Maternal smoking: age distribution levels of alpha-fetoprotein and human chorionic gonadotropin, and effect on detection of Down syndrome pregnancies in second-trimester screening. Prenat Diagn 22: 247-255.
5. Cuckle HS, Wald NJ, Densem JW, et al. 1990. The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotropin, progesterone and dehydroepiandrosterone sulphate. Br J Obstet Gynaecol 97: 272-276.
6. DeGraaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, VanLith JM. 2000. Co-variables in first trimester maternal serum screening. Prenat Diagn 20: 186-189.
7. Ferriman EL, Sehmi IK, Jones R, Cuckle HS. 1999. The effect of smoking in pregnancy on maternal serum inhibin A levels. Prenat Diagn 19: 372-374.
8. Haddow JE, Palomaki GE, Knight GJ. 1995. Effect of parity on human chorionic gonadotropin levels and Down syndrome screening. J Med Screen 2: 28-30.
9. Kagan KO, Frisova V, Nicolaides KH, Spencer K. 2007. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13 + 6 weeks of gestation. Prenat Diagn 27: 849-853.
10. Krantz DA, Hallahan TW, Macri VJ, Macri JN. 2005. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Prenat Diagn 25: 635-640.
11. Lambert-Messerlian G, Palomaki GE, Canick JA. 2009. Adjustment of serum markers in first trimester screening. J Med Screen 16: 102-103.
12. Lambert-Messerlian GM, Saller DN Jr, Tumber MB, French CA, Peterson CJ, Canick JA. 1998. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops. Prenat Diagn 18: 1061-1067.
13. Malone FD, Canick JA, Ball RH, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353(19): 2001-2011.
14. Miron P, Cote YP, Lambert J. 2008. Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy. Prenat Diagn 28: 180-185.
15. Neveux LM, Palomaki GE, Knight GJ, Haddow JE. 1996b. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 16: 29-34.
16. Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. 1996a. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 16: 1115-1119.
17. Niemimaa M, Heinonen S, Seppala M, Ryynanen M. 2003. The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotropin and nuchal translucency. Br J Obstet Gynaecol 110: 664-667.
18. Palomaki GE, Haddow JE, Knight GJ, et al. 1995. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 15: 713-723.
19. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. 1993. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Obstet Gynaecol 81: 675-678.
20. Perona M, Mancini G, Dall AD, Guaraldo V, Carbonara A. 1998. Influence of smoking habits on Down's syndrome risk evaluation at mid-trimester through biochemical screening. Int J Clin Lab Res 28: 179-182.
21. Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK. 2002. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Prenat Diagn 22: 893-897.
22. Spencer K. 1998. The influence of smoking on maternal serum AFP and free beta hCG level and the impact on screening for Down syndrome. Prenat Diagn 18: 225-234.
23. Spencer K. 1999. The influence of smoking on maternal serum PAPP-A and free beta hCG levels in the first trimester of pregnancy. Prenat Diagn 18: 225-234.
24. Spencer K, Bindra R, Cacho AM, Nicolaides KH. 2004. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 24(3): 169-193.
25. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH. 2005. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 25: 365-369.
26. Tislarić D, Brajenović-Milić B, Ristić S, et al. 2002. The influence of smoking and parity on serum markers for Down's syndrome screening. Fetal Diagn Ther 17: 17-21.
27. Wald NJ, Kennard A, Hackshaw A, McGuire A. 1997. Antenatal screening for Down's syndrome. J Med Screen 4: 181-246.
28. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen 10: 56-104.
29. Yitiger AB, Kavak ZN, Bakirci N, Gokasian H. 2006. Effect of smoking on pregnancy-associated plasma protein A, free beta-human chorionic gonadotropin, and nuchal translucency in the first trimester of pregnancy. Adv Ther 23: 131-138.